Brokerages Set Bright Minds Biosciences Inc. (NASDAQ:DRUG) PT at $83.25
Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Free Report) has been assigned an average recommendation of “Buy” from the six research firms that are presently covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month […]
Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Free Report) has been assigned an average recommendation of “Buy” from the six research firms that are presently covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month […]
